WallStreetZenWallStreetZen

AnalystsPeter Welford
Peter Welford's Stock Forecasts

Analyst Ranking
Bottom 17%
#3779 out of 4529 analysts
Average Return
-25.08%
Win Rate
25%1 out of 4
Risk vs Reward
Poor
Good

Peter Welford's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Gsk PLCGSK
+10.15%$38.92$42.87
2024-01-02 -
2024-03-28
Strong Buy

Peter Welford Analyst Color

Get additional color on Peter Welford's coverage of popular stocks

Peter Welford's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Gsk PLCGSK
1Strong Buy$48.00+11.97%Upgrades
3 months ago
Astrazeneca PLCAZN
1Strong Buy$80.00+18.08%Upgrades
6 months ago
Galapagos NvGLPG
2Hold$47.20N/AUpgrades
a year ago
Barinthus Biotherapeutics PLCBRNS
1Strong Buy$28.00N/AInitiates Coverage On
3 years ago
Celgene CorpCELG
2HoldN/AN/ADowngrades
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.